Abstract
Marine sponges represent a prolific and chemically diverse source of secondary metabolites, some of which feature hitherto unprecedented carbon skeletons that continue to attract the interest of natural product researchers. The novel chemistry of these metabolites is often accompanied by exceptional bioactivity profiles suggesting these compounds to be potential leads for drug discovery. In recent years, advances in chromatographic and spectroscopic techniques have allowed the identification of structurally complex natural products, even at nanomolar concentrations, thus uncovering the vast potential of marine sponges as sources of novel bioactive compounds. In this review, we present an overview on selected natural products reported from marine sponges from 2010 to 2016. In total, 182 different compounds belonging mainly to the groups of alkaloids, peptides, terpenoids, or polyketides are highlighted based on their unique structural features as well as on their reported bioactivities, which are primarily in the fields of anticancer agents, antibiotics, anti-inflammatory compounds, and neuroprotective agents.
Keywords: Marine natural products, sponges, unprecedented structures, alkaloids, peptides, terpenoids, polyketides.
Current Organic Chemistry
Title:Structurally Unprecedented Metabolites from Marine Sponges
Volume: 21 Issue: 5
Author(s): Elena Ancheeva, Mona El-Neketi, Weiguo Song, Wenhan Lin, Georgios Daletos, Weaam Ebrahim and Peter Proksch
Affiliation:
Keywords: Marine natural products, sponges, unprecedented structures, alkaloids, peptides, terpenoids, polyketides.
Abstract: Marine sponges represent a prolific and chemically diverse source of secondary metabolites, some of which feature hitherto unprecedented carbon skeletons that continue to attract the interest of natural product researchers. The novel chemistry of these metabolites is often accompanied by exceptional bioactivity profiles suggesting these compounds to be potential leads for drug discovery. In recent years, advances in chromatographic and spectroscopic techniques have allowed the identification of structurally complex natural products, even at nanomolar concentrations, thus uncovering the vast potential of marine sponges as sources of novel bioactive compounds. In this review, we present an overview on selected natural products reported from marine sponges from 2010 to 2016. In total, 182 different compounds belonging mainly to the groups of alkaloids, peptides, terpenoids, or polyketides are highlighted based on their unique structural features as well as on their reported bioactivities, which are primarily in the fields of anticancer agents, antibiotics, anti-inflammatory compounds, and neuroprotective agents.
Export Options
About this article
Cite this article as:
Ancheeva Elena, El-Neketi Mona, Song Weiguo, Lin Wenhan, Daletos Georgios, Ebrahim Weaam and Proksch Peter, Structurally Unprecedented Metabolites from Marine Sponges, Current Organic Chemistry 2017; 21 (5) . https://dx.doi.org/10.2174/1385272820666161017164957
DOI https://dx.doi.org/10.2174/1385272820666161017164957 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials?
Recent Patents on CNS Drug Discovery (Discontinued) A Review of <i>Saurauia roxburghii</i> Wall. (Actinidiacaea) as a Traditional Medicinal Plant, Its Phytochemical Study and Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Biology of Heme: Drug Interactions and Adverse Drug Reactions with CYP450
Current Topics in Medicinal Chemistry The DREAM of Pain Relief
Current Rheumatology Reviews Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease
Current Alzheimer Research Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Anti-Cancer Agents in Medicinal Chemistry Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats
Current Neurovascular Research The Serpin Solution; Targeting Thrombotic and Thrombolytic Serine Proteases in Inflammation
Cardiovascular & Hematological Disorders-Drug Targets An Insight into the New Anticonvulsant Agents
Current Topics in Medicinal Chemistry The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Efficacy, Duration and Timing of Withdrawal of Prophylactic Treatment with Antiepileptic Drugs in Neurosurgical Conditions
Current Pharmaceutical Design ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer’s Disease
Current Medicinal Chemistry Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
Current Pharmaceutical Design